ClearView Wealth has commenced a strategic review of its business, to determine among other things, the “optimal” future direction of the company to “protect and enhance” customer and policyholder outcomes.

The company announced the review last week in an investor update, saying it came about following an evaluation of its future capital structure and discussions with Crescent Capital Partners, its biggest shareholder.

“This review will assess ClearView’s strategic options to unlock and enhance value for ClearView shareholders, including potential change of control transactions,” the update says.

“The board will at all times protect customer and policyholder interests and there are no assurances that the ClearView board will decide to pursue any transaction, nor that any transaction or transactions will result from this review.”

ClearView Wealth says the last financial year has been a “transformational” period for the business, making it an ideal time to carry out the review.

The review comes after the business announced the sale of its advice units to Centrepoint Alliance and a strong FY21 performance, with its life arm driving overall operating earnings after-tax 83% higher to $23.9 million.